Clinical Trial Update: A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of Doxil (liposomal doxorubicin) and vinorelbine in patients with metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxil (liposomal doxorubicin)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Hematology Oncology Consultants | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN